Incidental prostate cancer diagnosed following a transurethral resection of the prostate: A national database analysis in England

Objectives: The aim was to compare prostate cancer and all-cause mortality in patients diagnosed with prostate cancer following a transurethral resection of the prostate (TURP) (incidental prostate cancer, IPC), to men diagnosed with localised non-incidental prostate cancer (NIPC). Patients and methods: Men diagnosed with localised prostate cancer between 2000 and 2008 were identified from the English national cancer registry. Their records were linked to the Hospital Episode Statistics (HES) database of hospital admissions in England to identify men who had a TURP. Men were considered to have IPC if prostate cancer was diagnosed less than 60 days after TURP. Mortality rates were calculated using the Kaplan–Meier method. Mortality rate ratios (RR) comparing IPC and NIPC were calculated with multivariable Poisson regression adjusting for age group, co-morbidities, year of diagnosis and radical treatment. Results: A total of 192,960 men were included. Of these, 6666 (3.5%) had IPC and 186,294 (96.5%) NIPC. Median follow-up was 4.7 years (0.5–11.0). Ten-year prostate cancer mortality was 17.1% in IPC, 19.0% in NIPC. With adjustment, the prostate cancer-specific mortality in IPC was 30% lower than NIPC (RR 0.70, 95% CI 0.65–0.75, p<0.001), with no difference in all-cause mortality. Conclusion: Ten-year prostate cancer mortality in IPC was 17%. Men with IPC had lower prostate cancer-specific mortality than other prostate cancer patients.

[1]  D. Greenberg,et al.  Are Transrectal Prostate Biopsies Routinely Indicated in Patients with Incidentally Diagnosed Prostate Cancer following Transurethral Resection of the Prostate for Benign Disease? , 2013, Urologia Internationalis.

[2]  J. Fütterer,et al.  ESUR prostate MR guidelines 2012 , 2012, European Radiology.

[3]  U. Capitanio,et al.  When should we expect no residual tumor (pT0) once we submit incidental T1a‐b prostate cancers to radical prostatectomy? , 2011, International journal of urology : official journal of the Japanese Urological Association.

[4]  Dirk F Moore,et al.  Outcomes of localized prostate cancer following conservative management. , 2009, JAMA.

[5]  J. Johansson,et al.  Incidence and mortality of incidental prostate cancer: a Swedish register-based study , 2008, British Journal of Cancer.

[6]  U. Capitanio,et al.  Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence. , 2008, European urology.

[7]  Jan van der Meulen,et al.  Charlson scores based on ICD-10 administrative data were valid in assessing comorbidity in patients undergoing urological cancer surgery. , 2006, Journal of clinical epidemiology.

[8]  Cheng‐Yen Chang,et al.  Transurethral Resection of the Prostate-Related Changes in the Prostate Gland: Correlation of MRI and Histopathology , 2000, Journal of computer assisted tomography.

[9]  Tombal,et al.  Assessing the risk of unsuspected prostate cancer in patients with benign prostatic hypertrophy: a 13‐year retrospective study of the incidence and natural history of T1a‐T1b prostate cancers , 1999, BJU international.

[10]  D. Bostwick,et al.  Predictors of cancer progression in T1a prostate adenocarcinoma , 1999 .

[11]  K. Akakura,et al.  DISEASE PROGRESSION IN STAGE A PROSTATE CANCER , 1995, International journal of urology : official journal of the Japanese Urological Association.

[12]  P. Walsh,et al.  Radical prostatectomy for impalpable prostate cancer: the Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C). , 1994, The Journal of urology.

[13]  M. Riggs,et al.  Long-term survival of stage A prostate carcinoma, atypical hyperplasia/adenosis and BPH. , 1994, British Journal of Cancer.

[14]  E. Pienkos,et al.  Incidental carcinoma of prostate, Long-term follow-up. , 1990, Urology.

[15]  I. Thompson,et al.  Extended follow-up of stage A1 carcinoma of prostate. , 1989, Urology.

[16]  P. Humphrey,et al.  The ratio of prostate chips with cancer: a new measure of tumor extent and its relationship to grade and prognosis. , 1988, Human pathology.

[17]  P. Walsh,et al.  Prognosis of untreated stage A1 prostatic carcinoma: a study of 94 cases with extended followup. , 1986, The Journal of urology.

[18]  M. Blute,et al.  Long-term followup of young patients with stage A adenocarcinoma of the prostate. , 1986, The Journal of urology.

[19]  A. Busuttil,et al.  Incidental carcinoma of the prostate: selection for deferred treatment. , 1983, British journal of urology.

[20]  P. Walsh,et al.  Pathological factors that influence prognosis in stage A prostatic cancer: the influence of extent versus grade. , 1981, The Journal of urology.